600572 logo

Zhejiang CONBA Pharmaceutical Co.,Ltd. Stock Price

SHSE:600572 Community·CN¥12.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

600572 Share Price Performance

CN¥0
-4.90 (-100.00%)
CN¥0
-4.90 (-100.00%)
Price CN¥0

600572 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Flawless balance sheet established dividend payer.

2 Risks
2 Rewards

Zhejiang CONBA Pharmaceutical Co.,Ltd. Key Details

CN¥6.6b

Revenue

CN¥3.1b

Cost of Revenue

CN¥3.5b

Gross Profit

CN¥2.8b

Other Expenses

CN¥688.0m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.27
52.46%
10.46%
5.6%
View Full Analysis

About 600572

Founded
1969
Employees
8411
CEO
Guoliang Luo
WebsiteView website
www.conbapharm.com

Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of pharmaceuticals and health products in mainland China. It offers medicines, Chinese patent medicines, chemical medicines, Chinese herbal medicine slices, and health products. The company also provides Chinese decoction pieces; over-the-counter medications; healthy consumer products, including nutritional supplements, hygiene products, healthy daily chemicals and food, and other self-care products; and processes agricultural products. In addition, it offers prescription pieces, formula granules, plant extracts, and other products. The company was formerly known as Lanxi Yunshan Pharmaceutical Factory and changed its name to Zhejiang CONBA Pharmaceutical Co.,Ltd. in October 1999. Zhejiang CONBA Pharmaceutical Co.,Ltd. was founded in 1969 and is headquartered in Hangzhou, China. Zhejiang CONBA Pharmaceutical Co.,Ltd. is a subsidiary of Zhejiang Traditional Chinese Medicine Health Industry Group Co., Ltd.

Recent 600572 News & Updates

Recent updates

No updates